THRIVE Score Predicts Outcomes With a Third-Generation Endovascular Stroke Treatment Device in the TREVO-2 Trial | Zendy

Alexander C. Flint | Zendy; Bin Xiang | Zendy; Rishi Gupta | Zendy; Raul G. Nogueira | Zendy; Helmi L. Lutsep | Zendy; Tudor Jovin | Zendy; Gregory W. Albers | Zendy; David S. Liebeskind | Zendy; Nerses Sanossian | Zendy; Wade S. Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

THRIVE Score Predicts Outcomes With a Third-Generation Endovascular Stroke Treatment Device in the TREVO-2 Trial

Author(s) -

Alexander C. Flint,

Bin Xiang,

Rishi Gupta,

Raul G. Nogueira,

Helmi L. Lutsep,

Tudor Jovin,

Gregory W. Albers,

David S. Liebeskind,

Nerses Sanossian,

Wade S. Smith

Publication year - 2013

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.113.002796

Subject(s) - medicine , stroke (engine) , failure to thrive , randomized controlled trial , receiver operating characteristic , surgery , mechanical engineering , engineering

Several outcome prediction scores have been tested in patients receiving acute stroke treatment with previous generations of endovascular stroke treatment devices. The TREVO-2 trial was a randomized controlled trial comparing a novel endovascular stroke treatment device (the Trevo device) to a previous-generation endovascular stroke treatment device (the Merci device).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research